Finally, we observed that, clinical NSCLC samples carrying EGFR mutations contain higher KDM1A level and lower TIMP3 expression, whereas those carrying Kras mutations have lower KDM1A level and higher TIMP3 expression (Supplementary Figure S2F). Here, KDM1A is linked to non-small cell lung carcinoma.